Literature DB >> 10190646

Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives?

D J Sheridan1, M P Kingsbury, N A Flores.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10190646      PMCID： PMC2014170          DOI： 10.1046/j.1365-2125.1999.00871.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  80 in total

1.  Cardiac function, coronary flow, and oxygen consumption in stable left ventricular hypertrophy.

Authors:  A B Malik; T Abe; H O'kane; A S Geha
Journal:  Am J Physiol       Date:  1973-07

2.  Premature mortality from coronary heart disease. The Framingham study.

Authors:  T Gordon; W B Kannel
Journal:  JAMA       Date:  1971-03-08       Impact factor: 56.272

3.  Myocardial blood flow distribution in concentric left ventricular hypertrophy.

Authors:  J C Rembert; L H Kleinman; J M Fedor; A S Wechsler; J C Greenfield
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

4.  Prevalence and natural history of electrocardiographic left ventricular hypertrophy.

Authors:  W B Kannel
Journal:  Am J Med       Date:  1983-09-26       Impact factor: 4.965

5.  Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study.

Authors:  D Levy; K M Anderson; D D Savage; S A Balkus; W B Kannel; W P Castelli
Journal:  Am J Cardiol       Date:  1987-09-01       Impact factor: 2.778

6.  Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group.

Authors: 
Journal:  JAMA       Date:  1982-09-24       Impact factor: 56.272

7.  Decreased coronary reserve: a mechanism for angina pectoris in patients with aortic stenosis and normal coronary arteries.

Authors:  M L Marcus; D B Doty; L F Hiratzka; C B Wright; C L Eastham
Journal:  N Engl J Med       Date:  1982-11-25       Impact factor: 91.245

8.  Effects of duration and severity of arterial hypertension and cardiac hypertrophy on coronary vasodilator reserve.

Authors:  R D Wangler; K G Peters; M L Marcus; R J Tomanek
Journal:  Circ Res       Date:  1982-07       Impact factor: 17.367

9.  Coronary vascular reserve in left ventricular hypertrophy secondary to chronic aortic regurgitation.

Authors:  A D Pichard; H Smith; J Holt; J Meller; R Gorlin
Journal:  Am J Cardiol       Date:  1983-01-15       Impact factor: 2.778

10.  Coronary flow studies in patients with left ventricular hypertrophy of the hypertensive type. Evidence for an impaired coronary vascular reserve.

Authors:  A D Pichard; R Gorlin; H Smith; J Ambrose; J Meller
Journal:  Am J Cardiol       Date:  1981-03       Impact factor: 2.778
View more
  6 in total

1.  Factors Contributing to Development and Reversal of LVH: A Pilot Study.

Authors:  Prasanna Kumar Hassan Ramaswamy; M Bhanukumar; Basavanagowdappa Hathur; K C Shashidhara; K M Srinath
Journal:  J Clin Diagn Res       Date:  2016-05-01

Review 2.  Evidence for distinct effects of exercise in different cardiac hypertrophic disorders.

Authors:  Emily J Johnson; Brad P Dieter; Susan A Marsh
Journal:  Life Sci       Date:  2015-01-26       Impact factor: 5.037

3.  Is hepatic steatosis associated with left ventricular mass index increase in the general population?

Authors:  Katharina Piontek; Carsten O Schmidt; Sebastian E Baumeister; Markus M Lerch; Julia Mayerle; Marcus Dörr; Stephan B Felix; Henry Völzke
Journal:  World J Hepatol       Date:  2017-07-08

4.  Inhibition of angiotensin II-induced cardiac hypertrophy and associated ventricular arrhythmias by a p21 activated kinase 1 bioactive peptide.

Authors:  Rui Wang; Yanwen Wang; Wee K Lin; Yanmin Zhang; Wei Liu; Kai Huang; Derek A Terrar; R John Solaro; Xin Wang; Yunbo Ke; Ming Lei
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

Review 5.  Tocotrienol is a cardioprotective agent against ageing-associated cardiovascular disease and its associated morbidities.

Authors:  Nardev Ramanathan; Esther Tan; Li Jun Loh; Boon Seng Soh; Wei Ney Yap
Journal:  Nutr Metab (Lond)       Date:  2018-01-19       Impact factor: 4.169

6.  The functional consequences of sodium channel NaV 1.8 in human left ventricular hypertrophy.

Authors:  Shakil Ahmad; Petros Tirilomis; Steffen Pabel; Nataliya Dybkova; Nico Hartmann; Cristina E Molina; Theodoros Tirilomis; Ingo Kutschka; Norbert Frey; Lars S Maier; Gerd Hasenfuss; Katrin Streckfuss-Bömeke; Samuel Sossalla
Journal:  ESC Heart Fail       Date:  2018-10-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.